| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0165-6147(98)01255-3 |
| P698 | PubMed publication ID | 9850608 |
| P2093 | author name string | T M Tzschentke | |
| W J Schmidt | |||
| P2860 | cites work | Competitive and non-competitive N-methyl-D-aspartate antagonists fail to prevent the induction of methamphetamine-induced sensitization | Q28318966 |
| Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats | Q28342678 | ||
| Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization | Q34420110 | ||
| The NMDA receptor competitive antagonist CPP modulates benzodiazepine tolerance and discontinuation | Q34449371 | ||
| The behavioral pharmacology of NMDA receptor antagonists | Q37863320 | ||
| Excitatory amino acid receptors and synaptic plasticity | Q37889910 | ||
| The contribution of Pavlovian conditioning to drug tolerance and dependence | Q39767699 | ||
| Excitatory amino acids and drugs of abuse: a role for N-methyl-d-aspartate receptors in drug tolerance, sensitization and physical dependence | Q40480630 | ||
| Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants | Q40530386 | ||
| The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants | Q41749963 | ||
| Amphetamine behavioral sensitization and the excitatory amino acids | Q44745120 | ||
| Locomotor-activating effects of the D2 agonist bromocriptine show environment-specific sensitization following repeated injections | Q44882687 | ||
| Does dizocilpine (MK-801) selectively block the enhanced responsiveness to repeated amphetamine administration? | Q46204457 | ||
| Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat | Q46904809 | ||
| The NMDA antagonist MK-801 can impair attention to exteroceptive stimuli | Q48103292 | ||
| MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. | Q48163465 | ||
| Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801. | Q48230956 | ||
| Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization | Q48267682 | ||
| Dopamine-glutamate interactions in the basal ganglia | Q48318964 | ||
| The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission | Q48612417 | ||
| Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine | Q48638665 | ||
| Dizocilpine prevents the development of tolerance to the sedative effects of diazepam in rats | Q48641419 | ||
| Synergistic effects of cocaine and dizocilpine (MK-801) on brain stimulation reward | Q48682122 | ||
| Progressive augmentation of striatal and accumbal preprotachykinin mRNA levels by chronic treatment with methamphetamine and effect of concurrent administration of the N-methyl-D-aspartate receptor antagonist MK-801. | Q48771524 | ||
| Systemic pretreatment with MK-801 (dizocilpine) increases breaking points for self-administration of cocaine on a progressive-ratio schedule in rats. | Q51558396 | ||
| Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopamine-receptor supersensitivity in mice. | Q51582999 | ||
| Inhibition of cocaine sensitization by MK-801, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: evaluation by ambulatory activity in mice. | Q51592919 | ||
| The NMDA receptor and cocaine: Evidence that MK-801 can induce behavioral sensitization effects | Q51597277 | ||
| Antagonist of N-methyl-D-aspartate receptors partially prevent the development of cocaine sensitization. | Q51616968 | ||
| Cocaine behavioral sensitization and the excitatory amino acids. | Q51631322 | ||
| Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. | Q51759796 | ||
| Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801 | Q52052445 | ||
| NMDA antagonists make learning and recall state-dependent. | Q52072564 | ||
| MK-801 inhibits methamphetamine-induced conditioned place preference and behavioral sensitization to apomorphine in mice. | Q52197218 | ||
| MK-801 (dizocilpine): synergist and conditioned stimulus in bromocriptine-induced psychomotor sensitization. | Q52202092 | ||
| N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. | Q52207692 | ||
| The development of behavioral sensitization to apomorphine is blocked by MK-801. | Q52222338 | ||
| Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. | Q52228738 | ||
| State dependent learning and morphine tolerance. | Q52252117 | ||
| The NMDA antagonist dizocilpine (M K801) attenuates tolerance to nicotine in rats. | Q52300234 | ||
| Effects of repeated MK-801 on ambulation in mice and in sensitization following methamphetamine | Q68042255 | ||
| Evidence for dissociable mechanisms of amphetamine- and stress-induced behavioral sensitization: effects of MK-801 and haloperidol pretreatment | Q71696058 | ||
| Sensitization to apomorphine-induced rotational behavior in 6-OHDA-lesioned rats: effects of NMDA antagonists on drug response | Q71725984 | ||
| MK-801 disrupts the expression but not the development of bromocriptine sensitization: a state-dependency interpretation | Q71930932 | ||
| NMDA antagonist effects on the development of L-dopa behavioral sensitization in rats | Q72201037 | ||
| The role of corticosteroids in the acquisition of sensitization to locomotor stimulant effects of MK-801 | Q72406897 | ||
| MK-801 prevents the development of behavioral sensitization during repeated morphine administration | Q72482348 | ||
| MK-801-induced symptoms of sensitization. The lack of correlation with the extracellular concentration of dopamine in the rat prefrontal cortex | Q72691779 | ||
| Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine | Q72747585 | ||
| A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants | Q73950418 | ||
| Does dizocilpine (MK-801) inhibit the development of morphine-induced behavioural sensitization in rats? | Q73994266 | ||
| Dizocilpine (MK801): use or abuse? | Q74537557 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 447-451 | |
| P577 | publication date | 1998-11-01 | |
| P1433 | published in | Trends in Pharmacological Sciences | Q2451474 |
| P1476 | title | Does the noncompetitive NMDA receptor antagonist dizocilpine (MK801) really block behavioural sensitization associated with repeated drug administration? | |
| P478 | volume | 19 |
| Q77343245 | An integrated view of pathophysiological models of schizophrenia |
| Q73598954 | Differential effects of quinolinic acid lesions of the medial prefrontal cortex on the expression of morphine- and dizocilpine- induced behavioural plasticity in the rat |
| Q34372253 | Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. |
| Q34970664 | Experimental genetic approaches to addiction. |
| Q46815350 | Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine |
| Q52022912 | Memory of an operant response and of depressed mood retained in activation states of 5-HT(1A) receptors: evidence from rodent models. |
| Q46906799 | NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats |
| Q52176677 | NMDA receptors and behavioural sensitization: beyond dizocilpine. |
| Q42689768 | Naltrexone potentiates both amnestic and anxiolytic effects of chlordiazepoxide in mice |
| Q43875632 | Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors. |
| Q44540861 | The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism |
| Q51396429 | The dopamine antagonist sch 23390 reverses dizocilpine-induced blockade of cocaine sensitization. |
| Q95301997 | Tzschentke and schmidt reply |
| Q43662467 | Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats |
Search more.